Top-News
Werbung
Attraktive Knock-Outs auf Medtronic plc
Typ Hebel Bid / Ask WKN
Call
5,0 1,74 € / 1,75 €
SX4X25
Typ Hebel Bid / Ask WKN
Put
4,7 1,84 € / 1,85 €
SD53WC
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Medtronic plc

Medtronic Aktie News

Aktie
WKN:  A14M2J ISIN:  IE00BTN1Y115 US-Symbol:  MDT Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Irland
87,475 €
-0,18 €
-0,21%
07:26:48 Uhr
Depot/Watchlist
Marktkapitalisierung *
105,59 Mrd. €
Streubesitz
11,20%
KGV
23,41
Dividende
0,71 $
Dividendenrendite
0,70%
neu: Nachhaltigkeits-Score
40 %
Index-Zuordnung
S&P 500
Weiter abwärts? Short handeln - Jetzt mit Hebel 7,96: VH2V0C
Werbung

Medtronic News

04.12.25 - PR Newswire
Medtronic announces cash dividend for third quarter of fiscal year 2026
Medtronic announces cash dividend for third quarter of fiscal year 2026 PR Newswire
03.12.25 - PR Newswire
Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures
Medtronic announces FDA clearance of Hugo™ robotic-​assisted surgery system for urologic surgical procedures PR Newswire
02.12.25 - PR Newswire
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott
Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott PR Newswire
19.11.25 - Société Générale
Medtronic – Ausbruch nach Zahlen
Die Aktie des Medizintechnik-​Konzerns  Medtronic  Inc. (WKN: A14M2J) hatte im September 2021 ein Rekordhoch bei 135,89 USD markiert. Der anschließende Abwärtstrend drückte ...
18.11.25 - Der Aktionär
AKTIONÄR‑Tipp Medtronic: Starke Zahlen, höhere Prognose – Aktie mit Kaufsignal
18.11.25 - PR Newswire
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum
Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum PR Newswire
18.11.25 - wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Heute im Fokus: Bertelsmann, Medtronic, Biontech, Rheinmetall & Imperial Brands
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
05.11.25 - PR Newswire
Medtronic to announce financial results for its second quarter of fiscal year 2026
Medtronic to announce financial results for its second quarter of fiscal year 2026 PR Newswire
28.10.25 - PR Newswire
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system PR Newswire
26.10.25 - PR Newswire
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
Three-​year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-​based blood pressure reductions PR Newswire
09.10.25 - PR Newswire
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions PR Newswire
08.10.25 - PR Newswire
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-​assisted surgery system for gynecological procedures PR Newswire
29.09.25 - PR Newswire
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes PR Newswire
19.09.25 - PR Newswire
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence PR Newswire
15.09.25 - PR Newswire
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
Medtronic Announces Pricing of €1.5 Billion of Senior Notes PR Newswire
15.09.25 - PR Newswire
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
Medtronic initiates global pivotal study of cardiac pacing in a new patient population PR Newswire
04.09.25 - PR Newswire
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Study of Medtronic Hugo™ robotic-​assisted surgery system in hernia repair meets safety and effectiveness endpoints PR Newswire
02.09.25 - PR Newswire
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes PR Newswire
29.08.25 - PR Newswire
Medtronic executives to speak at upcoming investor conferences
Medtronic executives to speak at upcoming investor conferences PR Newswire
27.08.25 - ARIVA.DE Redaktion
"Keine gute Idee, noch Techs zu kaufen": Stattdessen sollten Anleger diese 8 Aktien jetzt genauer prüfen!
Technologieaktien haben in den vergangenen Jahren Rekordniveaus erreicht. Anleger setzen weiter auf das Wachstum von Chipproduzenten wie Nvidia und Softwarekonzernen wie ...

Newssuche

Videos

newspaper
02.12.25 +8,18%
Technical Trading: DAX Long dienstags
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »